Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023292014> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2023292014 endingPage "749" @default.
- W2023292014 startingPage "747" @default.
- W2023292014 abstract "Advanced age-related macular degeneration (AMD) is an important cause of visual loss in persons 65 years of age or older. 1 Tielsch JM. Vision problems in the U.S. A report on blindness and vision impairment in adults age 40 and older. Schaumburg, IL: Prevent Blindness America, 1995:1–20 Google Scholar , 2 Klein R. Wang Q. Klein B.E.K. Moss S.E. Meuer S.M. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995; 36: 182-191 PubMed Google Scholar Its pathogenesis remains poorly understood. Until recently, only photocoagulation and photodynamic therapy were shown to have some benefit in preventing severe visual loss but only in a small percentage of patients with the neovascular form of the disease and only for a limited time after treatment. 3 Bressler N.M. Bressler S.B. Fine S.L. Age-related macular degeneration. Surv Ophthalmol. 1988; 32: 375-413 Abstract Full Text PDF PubMed Scopus (749) Google Scholar , 4 Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 1993;111:1189–1199 Google Scholar , 5 Bressler N.M. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin two-year results of 2 randomized clinical trials–TAP report 2. Arch Ophthalmol. 2001; 119: 198-207 PubMed Google Scholar Aside from antioxidants and zinc, which were shown in the Age-Related Eye Disease Study to reduce progression to advanced AMD (23% vs 28%) in persons with early AMD compared with those not on this treatment, there have been no proven medical interventions for preventing the progression of this disease. 6 Age-Related Eye Disease Study Research GroupA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age- related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol. 2001; 119: 1417-1436 Crossref PubMed Scopus (2466) Google Scholar" @default.
- W2023292014 created "2016-06-24" @default.
- W2023292014 creator A5026764667 @default.
- W2023292014 creator A5061631272 @default.
- W2023292014 date "2004-04-01" @default.
- W2023292014 modified "2023-10-16" @default.
- W2023292014 title "Do statins prevent age-related macular degeneration?" @default.
- W2023292014 cites W1491820399 @default.
- W2023292014 cites W1580351516 @default.
- W2023292014 cites W1601975653 @default.
- W2023292014 cites W1966622202 @default.
- W2023292014 cites W1985423172 @default.
- W2023292014 cites W1988191877 @default.
- W2023292014 cites W1995728499 @default.
- W2023292014 cites W2025176768 @default.
- W2023292014 cites W2104421727 @default.
- W2023292014 cites W2106036809 @default.
- W2023292014 cites W2123883528 @default.
- W2023292014 cites W2148959041 @default.
- W2023292014 cites W2153590450 @default.
- W2023292014 cites W2413548364 @default.
- W2023292014 cites W2598520882 @default.
- W2023292014 doi "https://doi.org/10.1016/j.ajo.2004.01.037" @default.
- W2023292014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15059716" @default.
- W2023292014 hasPublicationYear "2004" @default.
- W2023292014 type Work @default.
- W2023292014 sameAs 2023292014 @default.
- W2023292014 citedByCount "6" @default.
- W2023292014 countsByYear W20232920142022 @default.
- W2023292014 crossrefType "journal-article" @default.
- W2023292014 hasAuthorship W2023292014A5026764667 @default.
- W2023292014 hasAuthorship W2023292014A5061631272 @default.
- W2023292014 hasConcept C118487528 @default.
- W2023292014 hasConcept C134018914 @default.
- W2023292014 hasConcept C2776403814 @default.
- W2023292014 hasConcept C2778257484 @default.
- W2023292014 hasConcept C2778313320 @default.
- W2023292014 hasConcept C2779093074 @default.
- W2023292014 hasConcept C2781116099 @default.
- W2023292014 hasConcept C2781148688 @default.
- W2023292014 hasConcept C2781359195 @default.
- W2023292014 hasConcept C2908861002 @default.
- W2023292014 hasConcept C555293320 @default.
- W2023292014 hasConcept C71924100 @default.
- W2023292014 hasConceptScore W2023292014C118487528 @default.
- W2023292014 hasConceptScore W2023292014C134018914 @default.
- W2023292014 hasConceptScore W2023292014C2776403814 @default.
- W2023292014 hasConceptScore W2023292014C2778257484 @default.
- W2023292014 hasConceptScore W2023292014C2778313320 @default.
- W2023292014 hasConceptScore W2023292014C2779093074 @default.
- W2023292014 hasConceptScore W2023292014C2781116099 @default.
- W2023292014 hasConceptScore W2023292014C2781148688 @default.
- W2023292014 hasConceptScore W2023292014C2781359195 @default.
- W2023292014 hasConceptScore W2023292014C2908861002 @default.
- W2023292014 hasConceptScore W2023292014C555293320 @default.
- W2023292014 hasConceptScore W2023292014C71924100 @default.
- W2023292014 hasIssue "4" @default.
- W2023292014 hasLocation W20232920141 @default.
- W2023292014 hasLocation W20232920142 @default.
- W2023292014 hasOpenAccess W2023292014 @default.
- W2023292014 hasPrimaryLocation W20232920141 @default.
- W2023292014 hasRelatedWork W1989708710 @default.
- W2023292014 hasRelatedWork W2012520468 @default.
- W2023292014 hasRelatedWork W2020860662 @default.
- W2023292014 hasRelatedWork W2079623327 @default.
- W2023292014 hasRelatedWork W2109537563 @default.
- W2023292014 hasRelatedWork W2155781417 @default.
- W2023292014 hasRelatedWork W2406792734 @default.
- W2023292014 hasRelatedWork W2414943111 @default.
- W2023292014 hasRelatedWork W2552805656 @default.
- W2023292014 hasRelatedWork W4232931681 @default.
- W2023292014 hasVolume "137" @default.
- W2023292014 isParatext "false" @default.
- W2023292014 isRetracted "false" @default.
- W2023292014 magId "2023292014" @default.
- W2023292014 workType "article" @default.